Adaptive Biotechnologies Corp (ADPT) Insider Trading
- $5,244,000.00
- $581,339,172.25
- March 5, 2026
- Chad M Robins
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 5, 2026 | COO | 30,941 | $16.00 | Sell | $495,056.00 | |
| March 3, 2026 | Insider | 14,233 | $16.52 | Sell | $235,129.16 | |
| March 3, 2026 | COO | 30,941 | $15.67 | Sell | $484,845.47 | |
| March 3, 2026 | CEO | 53,083 | $15.52 | Sell | $823,848.16 | |
| March 2, 2026 | CEO | 289,024 | $15.82 | Sell | $4,572,359.68 | |
| March 2, 2026 | Insider | 10,000 | $15.72 | Sell | $157,200.00 | |
| Feb. 27, 2026 | CEO | 182,891 | $15.99 | Sell | $2,924,427.09 | |
| Feb. 4, 2026 | CFO | 2,145 | $18.46 | Sell | $39,596.70 | |
| Feb. 3, 2026 | Insider | 8,120 | $19.00 | Sell | $154,280.00 | |
| May 16, 2025 | CFO | 1,929 | $8.89 | Sell | $17,148.81 | |
| May 1, 2025 | Insider | 68,412 | $7.35 | Sell | $502,828.20 | |
| March 24, 2025 | Insider | 1,698 | $9.00 | Sell | $15,282.00 | |
| March 12, 2025 | Director | 53,000 | $7.59 | Sell | $402,270.00 | |
| March 10, 2025 | Director | 10,000 | $7.05 | Sell | $70,500.00 | |
| March 6, 2025 | Director | 15,664 | $7.94 | Sell | $124,372.16 | |
| March 5, 2025 | CEO | 117,351 | $6.98 | Sell | $819,109.98 | |
| March 5, 2025 | COO | 59,505 | $6.98 | Sell | $415,344.90 | |
| March 5, 2025 | Insider | 20,875 | $6.99 | Sell | $145,916.25 | |
| March 5, 2025 | CFO | 10,320 | $6.98 | Sell | $72,033.60 | |
| Feb. 20, 2025 | CEO | 99,107 | $8.44 | Sell | $836,463.08 | |
| Feb. 18, 2025 | CEO | 211,160 | $8.50 | Sell | $1,794,860.00 | |
| Feb. 14, 2025 | CEO | 158,921 | $8.46 | Sell | $1,344,471.66 | |
| Nov. 18, 2024 | CFO | 248 | $4.98 | Sell | $1,235.04 | |
| March 5, 2024 | President | 39,070 | $3.47 | Sell | $135,572.90 | |
| March 5, 2024 | SVP | 13,381 | $3.43 | Sell | $45,896.83 | |
| March 5, 2024 | Insider | 7,727 | $3.43 | Sell | $26,503.61 | |
| March 5, 2024 | CEO | 48,673 | $3.43 | Sell | $166,948.39 | |
| March 5, 2024 | CFO | 15,456 | $3.44 | Sell | $53,168.64 | |
| Nov. 16, 2023 | Insider | 259 | $4.13 | Sell | $1,069.67 | |
| Aug. 7, 2023 | Insider | 5,652 | $6.78 | Sell | $38,320.56 | |
| June 20, 2023 | CFO | 134,961 | $8.14 | Sell | $1,098,582.54 | |
| June 15, 2023 | CFO | 70,000 | $8.53 | Sell | $597,100.00 | |
| June 2, 2023 | CFO | 38,000 | $7.16 | Sell | $272,080.00 | |
| April 10, 2023 | COO | 817 | $8.50 | Sell | $6,944.50 | |
| March 27, 2023 | Director | 2,341 | $8.49 | Sell | $19,875.09 | |
| March 6, 2023 | President | 22,668 | $8.57 | Sell | $194,264.76 | |
| March 6, 2023 | SVP | 5,491 | $8.57 | Sell | $47,057.87 | |
| March 6, 2023 | COO | 6,529 | $8.57 | Sell | $55,953.53 | |
| March 6, 2023 | Insider | 3,529 | $8.57 | Sell | $30,243.53 | |
| Jan. 9, 2023 | COO | 995 | $8.50 | Sell | $8,457.50 | |
| Nov. 16, 2022 | Insider | 959 | $8.87 | Sell | $8,506.33 | |
| Nov. 1, 2022 | Insider | 31,066 | $8.00 | Sell | $248,528.00 | |
| Oct. 10, 2022 | COO | 2,284 | $7.13 | Sell | $16,284.92 | |
| Oct. 7, 2022 | COO | 841 | $7.61 | Sell | $6,400.01 | |
| Aug. 5, 2022 | Insider | 17,540 | $10.98 | Sell | $192,589.20 | |
| July 8, 2022 | Chief Operating Officer | 2,300 | $10.47 | Sell | $24,081.00 | |
| July 7, 2022 | COO | 825 | $9.53 | Sell | $7,862.25 | |
| July 7, 2022 | Chief Operating Officer | 825 | $9.53 | Sell | $7,862.25 | |
| April 7, 2022 | COO | 831 | $13.17 | Sell | $10,944.27 | |
| March 9, 2022 | CEO | 14,815 | $12.46 | Sell | $184,594.90 |
Insiders are both buying and selling Adaptive Biotechnologies Corp stock.
The insider traders at Adaptive Biotechnologies Corp are: Chad M Robins, Harlan S Robins, Julie Rubinstein, Chad M Cohen, Stacy L Taylor, Sharon Benzeno, R Mark Adams, Michelle Renee Griffin, Lance Baldo, Francis Lo, Nancy Louise Hill, Kyle Piskel, Robert Hershberg, Eric Dobmeier, Jyoti Palaniappan, Tycho Peterson, Nitin Sood, David E Goel, Charles Sang, Viking Global Performance Llc, Chad M. Robins, Global Investors Lp Viking, Harlan S. Robins, ADAMS R MARK, Michael J Pellini, Chad M. Cohen, Susan Bobulsky, Andris A Zoltners, and Peter M Neupert
The most active insider trader at Adaptive Biotechnologies Corp is Chad M Robins with 44 trades.
Viking Global Performance Llc has sold the most Adaptive Biotechnologies Corp stock with a total value of $245,448,434.04.
Viking Global Performance Llc has bought the most Adaptive Biotechnologies Corp stock with a total value of $10,000,000.00.
The most recent insider trade for Adaptive Biotechnologies Corp was on March 5, 2026.
The single biggest insider buy for Adaptive Biotechnologies Corp was from Viking Global Performance Llc with a total value of $5,000,000.00 on July 1, 2019.
The single biggest insider sell for Adaptive Biotechnologies Corp was from Global Investors Lp Viking with a total value of $123,800,000.00 on Nov. 11, 2020.
